Skip to content

Clinical trials

Phase 3 COVID-19 trials in Indonesia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: Indonesia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20206
20215
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status6
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dr. Soetomo General Hospital2
Indonesia University2
PT Bio Farma2
Baiturrahmah University1
Genova Inc.1
Ina-Respond1
Livzon Pharmaceutical Group Inc.1
Murdoch Childrens Research Institute1
Universitas Sriwijaya1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1915
Communicable Diseases1
Community-Acquired Pneumonia1
Infections1
Pneumonia1
Severe Acute Respiratory Syndrome1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.